Spectral AI, Inc.

Spectral AI, Inc., trading under the ticker RCLF, is a medical-technology company focused on artificial-intelligence-powered wound assessment, with its flagship DeepView platform using hyperspectral imaging and deep learning to evaluate burn wound severity at the point of care. The company reached public markets through a SPAC business combination and filed an S-1/A amendment with the SEC on January 23, 2024, bearing accession number 0001213900-24-005801, reflecting updates to its registration statement as a newly public entity. Spectral AI operates within the healthcare and medical-device sector, targeting a clinical need in burn and wound-care diagnostics. Visit SpacDesk and sign up for full data on RCLF, including deal timelines, filing history, and comparable transactions.